PharmGKB summary: heparin-induced thrombocytopenia pathway, adverse drug reaction

Pharmacogenet Genomics. 2022 Apr 1;32(3):117-124. doi: 10.1097/FPC.0000000000000465.

Authors

Elise Miller¹, Charles Norwood¹, Jason B Giles¹, Rachel Huddart², Jason H Karnes^{1

3}, Michelle Whirl-Carrillo², Teri E Klein^{2

4}

Affiliations

¹ Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Tucson, Arizona.
² Department of Biomedical Data Science, Stanford University, Stanford, California.
³ Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.
⁴ Department of Biomedical Informatics Research, Stanford University, Stanford, California, USA.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural

MeSH terms

Anticoagulants / adverse effects
Drug-Related Side Effects and Adverse Reactions*
Heparin / adverse effects
Humans
Thrombocytopenia* / chemically induced

Substances

Anticoagulants
Heparin

Grants and funding